cancer therapy

LONDON and PHILADELPHIA, June 1, 2026 Avacta Therapeutics announced updated Phase 1a/1b clinical results for faridoxorubicin (AVA6000) at the...

BOSTON, May 29, 2026 Ratio Therapeutics has expanded its manufacturing collaboration with PharmaLogic Holdings Corp. to support the clinical...

SUZHOU, China, May 29, 2026 Suzhou Ribo Life Science and Ribocure Pharmaceuticals (collectively “Ribo”) have announced the submission of...

SHANGHAI and HONG KONG, China, May 28, 2026 Antengene has announced a major clinical development milestone after receiving endorsement...

Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...

WOBURN, Massachusetts, May 21, 2026 Rgenta Therapeutics announced positive preliminary results from its ongoing Phase 1a/b clinical trial evaluating...

SAN DIEGO, Calif., May 21, 2026 Cardiff Oncology, Inc. announced that updated data from its ongoing Phase 2 CRDF-004...

WILMINGTON, Del. & SAN FRANCISCO, May 19, 2026 Incyte and Edison Scientific have announced a strategic collaboration aimed at...

ESPOO, Finland, May 21, 2026 Orion Pharma announced that it will present the first clinical data from its ongoing...

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...